Medical Marijuana, Inc. Garners International News Coverage in Westword Newspaper, Trade Outlets for Selling World’s Only Hops-Derived CBD Product

SAN DIEGO, Aug. 9, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered global news coverage in Westword newspaper and other outlets for its partnership with Peak Health to distribute the first-ever, and only, hops (Kriya brand Humulus)-derived cannabidiol (CBD) product ImmunAg™.

“We are honored to have our Real Scientific Humulus Oil featured in so many noteworthy publications,” Medical Marijuana, Inc. CEO Dr. Stuart Titus said. “We’re proud to be the only U.S. distributor of such an innovative product as the world’s only Humulus-derived CBD.”

As reported in numerous media outlets, including Westword newspaper and leading trade press outlet Merry Jane, Medical Marijuana, Inc. is currently the only U.S. distributor of ImmunAG™ and the product is sold in tincture form as Real Scientific Humulus Oil (RSHO-K) by subsidiary HempMeds® and as Premium Humulus Oil by subsidiary Kannaway®. ImmunAG™ is an extract of the Kriya brand Humulus plant, which is a variety of hops. Like hemp extract, the Kriya brand Humulus extract has a high concentration of CBD. Unlike CBD products derived from cannabis, which may contain trace amounts of THC, ImmunAG™ contains no THC.

The process that ImmunAg™ creator and partner Dr. Bomi Joseph used to create Kriya brand Humulus is detailed in the Westword article “World’s First Non-Cannabis CBD Oil Is High on Hops.” The article states “Joseph and his team meticulously selected and cross-bred plants with high concentrations of CBD until they arrived at a variety — Kriya brand Humulus  — with an 18 percent CBD concentration. Joseph holds a patent for this as well as the modification of any other Humulus plant to produce CBD and cannabinoids.”

The Merry Jane article, “California Company Creates First CBD Oil Made From Hops, Not Cannabis or Hemp,” stated that “While these bills slowly make their way through the legislative process, a San Francisco-based company just discovered another interesting way around the problem — by creating a new CBD extract.”

The news was also featured in other publications including The Fresh ToastCivilized420 Intel and Hemp Gazette.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.

About HempMeds®

HempMeds® was the first company to make CBD products available in bulk for U.S. consumers and provide high-quality CBD oil to customers around the world. HempMeds® was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Brazil, Argentina, Mexico and Paraguay.

About Peak Health

Peak Health Center is a 501(c)(3), Not-For-Profit Corporation, based out of Los Gatos, CA. Its charter is to improve human health, with the least use of pharmaceutical drugs. Its researchers from around the globe are volunteering efforts to enhance our knowledge of endogenous health and phytotherapy.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil. In addition, the company now produces legal Humulus-based products, which are considered GRAS and a “food ingredient”.


Public Relations Contact:

Andrew Hard

Chief Executive Officer CMW Media

P. 858-264-6600

[email protected]